BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1300511)

  • 1. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
    Moerlein SM; Perlmutter JS; Welch MJ
    Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
    Moerlein SM; Perlmutter JS; Markham J; Welch MJ
    J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
    Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
    J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of 5-(2'-[18F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography.
    Moerlein SM; Perlmutter JS
    Eur J Pharmacol; 1992 Jul; 218(1):109-15. PubMed ID: 1327820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding.
    Moerlein SM; Banks WR; Parkinson D
    Int J Rad Appl Instrum A; 1992 Jul; 43(7):913-7. PubMed ID: 1321101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.
    Perlmutter JS; Moerlein SM; Hwang DR; Todd RD
    J Neurosci; 1991 May; 11(5):1381-9. PubMed ID: 1827499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
    Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
    Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.
    Blin J; Pappata S; Kiyosawa M; Crouzel C; Baron JC
    Eur J Pharmacol; 1988 Feb; 147(1):73-82. PubMed ID: 3259509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
    Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
    J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain.
    Mach RH; Ehrenkaufer RL; Greenberg JH; Shao L; Morton TE; Evora PH; Nowak PA; Luedtke RR; Cohen D; Reivich M
    Synapse; 1995 Mar; 19(3):177-87. PubMed ID: 7784958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography.
    Moerlein SM; Laufer P; Stöcklin G; Pawlik G; Wienhard K; Heiss WD
    Eur J Nucl Med; 1986; 12(4):211-6. PubMed ID: 2876896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
    Boy C; Klimke A; Holschbach M; Herzog H; Mühlensiepen H; Rota Kops E; Sonnenberg F; Gaebel W; Stöcklin G; Markstein R; Müller-Gärtner HW
    Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol.
    Schönfeldt-Lecuona C; Juengling FD; Connemann BJ; Reske SN; Spitzer M; Kassubek J
    J Clin Psychopharmacol; 2004 Feb; 24(1):97-8. PubMed ID: 14709957
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine receptor-mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro[18F]fluoroepibatidine.
    Ding YS; Logan J; Bermel R; Garza V; Rice O; Fowler JS; Volkow ND
    J Neurochem; 2000 Apr; 74(4):1514-21. PubMed ID: 10737608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.